Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation

被引:316
作者
Hofma, SH [1 ]
van der Giessen, WJ [1 ]
van Dalen, BM [1 ]
Lemos, PA [1 ]
McFadden, EP [1 ]
Sianos, G [1 ]
Ligthart, JMR [1 ]
van Essen, D [1 ]
de Feyter, PJ [1 ]
Serruys, PW [1 ]
机构
[1] Erasmus MC, Thoraxctr, Dept Cardiol, NL-3015 GD Rotterdam, Netherlands
关键词
coronary stents; drugs; endothelium;
D O I
10.1093/eurheartj/ehi571
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Endothelial dysfunction has been related both to progression of atherosclerotic disease and to future cardiovascular events. We assessed local epicardial endothelial function 6 months after sirolimus-eluting stent (SES) or bare metal stent (BS) implantation. Methods and results In 12 patients (seven SES, five BS), endothelium-dependent vasomotion of a coronary segment 15 mm in length, starting 2 mm distal to the stent, was assessed with quantitative coronary angiography immediately after the procedure and at 6 months follow-up, after intracoronary infusion of acetylcholine. Intravascular ultrasound (IVUS) was performed and coronary flow reserve (CFR) assessed in all patients. At follow-up significant vasoconstriction was seen in SES (median 32% diameter reduction from baseline) but not in BS (median 2% reduction) patients after acetylcholine infusion (P=0.03 for SES vs. BS); endothelium-independent vasodilatation to nitrates did not differ significantly between groups (20% SES, 5% BS, P=0.14). IVUS revealed no late unhealed dissections and CFR was comparable between groups (SES 3.1 vs. BS 3.2, n.s.). Conclusion SES implantation may have an adverse effect on local endothelium-dependent vasomotor responses compared with BS implantation at 6 months. Long-term clinical consequences of this observation are still unknown.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 17 条
  • [1] Long-term endothelial dysfunction after coronary artery stenting
    Caramori, PRA
    Lima, VC
    Seidelin, PH
    Newton, GE
    Parker, JD
    Adelman, AG
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (06) : 1675 - 1679
  • [2] EFFECT OF RAPAMYCIN ON RAT AORTIC RING VASOMOTION
    CORBIN, F
    BLAISE, GA
    PARENT, M
    CHEN, HF
    DALOZE, PM
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 (05) : 813 - 817
  • [3] Local drug delivery via a coronary stent with programmable release pharmacokinetics
    Finkelstein, A
    McClean, D
    Kar, S
    Takizawa, K
    Varghese, K
    Baek, N
    Park, K
    Fishbein, MC
    Makkar, R
    Litvack, F
    Eigler, NL
    [J]. CIRCULATION, 2003, 107 (05) : 777 - 784
  • [4] Functional anatomy and hemodynamic characteristics of vasa vasorum in the walls of porcine coronary arteries
    Gössl, M
    Rosol, M
    Malyar, NM
    Fitzpatrick, LA
    Beighley, PE
    Zamir, M
    Ritman, EL
    [J]. ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY, 2003, 272A (02): : 526 - 537
  • [5] Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
    Guba, M
    von Breitenbuch, P
    Steinbauer, M
    Koehl, G
    Flegel, S
    Hornung, M
    Bruns, CJ
    Zuelke, C
    Farkas, S
    Anthuber, M
    Jauch, KW
    Geissler, EK
    [J]. NATURE MEDICINE, 2002, 8 (02) : 128 - 135
  • [6] Comparative study of cyclosporine and tacrolimus vs newer Immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function
    Jeanmart, H
    Malo, O
    Carrier, M
    Nickner, C
    Desjardins, N
    Perrault, LP
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (09) : 990 - 998
  • [7] PARADOXICAL VASOCONSTRICTION INDUCED BY ACETYLCHOLINE IN ATHEROSCLEROTIC CORONARY-ARTERIES
    LUDMER, PL
    SELWYN, AP
    SHOOK, TL
    WAYNE, RR
    MUDGE, GH
    ALEXANDER, RW
    GANZ, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (17) : 1046 - 1051
  • [8] A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
    Morice, M
    Serruys, PW
    Sousa, JE
    Fajadet, J
    Hayashi, EB
    Perin, M
    Colombo, A
    Schuler, G
    Barragan, P
    Guagliumi, G
    Molnar, F
    Falotico, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) : 1773 - 1780
  • [9] Three-year follow-up of the RAVEL study:: A randomized study with the sirolimus-eluting Bx VELOCITY™ stent in the treatment of patients with de novo native coronary artery lesions
    Morice, MC
    Serruys, P
    Costantini, C
    Wuelfert, E
    Wijns, W
    Fajadet, J
    Colombo, A
    Guagliumi, G
    Molnar, F
    Hayashi, EB
    Sousa, JE
    Perin, M
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 87A - 88A
  • [10] Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
    Moses, JW
    Leon, MB
    Popma, JJ
    Fitzgerald, PJ
    Holmes, DR
    O'Shaughnessy, C
    Caputo, RP
    Kereiakes, DJ
    Williams, DO
    Teirstein, PS
    Jaeger, JL
    Kuntz, RE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (14) : 1315 - 1323